Bayer HealthCare opened its new U.S. headquarters on a 94-acre campus in Whippany, New Jersey. Its new Headquarters consolidates Bayer HealthCare's operations that previously operated from Morristown, Montville and Wayne, New Jersey and Tarrytown, New York into one location.
Housed in two environmentally-friendly buildings, connected by a 5-story glass atrium, the 700,000 square-foot-office space features state-of-the-art technology and a modern open design for the approximately 2,400 employees now based at the new location.
"Bayer HealthCare is honored to now be a part of a community where we can continue to grow and thrive. We have a longstanding history of favorable results in research and development that has led to innovative products that make people's lives better," said Phil Blake, Bayer Corporation President. "The opening of our new Headquarters culminates the incredible year that Bayer has experienced, with the introduction of five new drugs ranging from Oncology to Women's Healthcare to Cardiovascular."
"Although the aim of this project is to bring our employees together in one location, this initiative is about growing together as well as building the brand and reputation of our company," said Marijn Dekkers, Chairman, Bayer AG Group, Board of Management. "Whippany is our footprint on the East Coast now, as we invest further in the U.S."
"New Jersey has a long and rich heritage as the hub of the pharmaceutical industry in the United States," said Gov. Chris Christie. "Since taking office, my Administration has put in place business-friendly policies so that companies like Bayer can continue to grow in New Jersey. This new facility will provide a state-of-the-art workplace for more than 2,000 employees while promoting responsible environmentally-friendly policies and practices. I congratulate and thank Bayer for their commitment to our state and residents."